Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Raw sequence reads of paired tumor and normal tissue samples from colorectal cancer patients

PROVIDER: PRJNA1079014 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28084103_1.fastq.gz	Fastqsanger.gz
	SRR28084103_2.fastq.gz	Fastqsanger.gz
	SRR28084104_1.fastq.gz	Fastqsanger.gz
	SRR28084104_2.fastq.gz	Fastqsanger.gz
	SRR28084105_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 144

Similar Datasets

RNA-seq of two paired normal and cancer tissues in two stage III colorectal cancer patients

Project description:The RNA from two paired normal and colorectal tumor tissue were sequenced by Illumina genome analyzer. 0.8 to 1.1 million reads were generated. Sequencing data was aligned with human RNA, human mitochondrial DNA and human genomic DNA by BWA. Base calling and Phred-like score was calculated by SAMTools. Whole transcriptome sequence of paired normal and tumor tissues obtained from two colorectal cancer patients

2011-05-28 | E-GEOD-29580 | biostudies-arrayexpress

DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer

Project description:DNA methylation in colorectal cancer diagnosis. The Illumina GoldenGate Methylation Cancer Panel I was used to select a set of candidates markers informative of colorectal cancer diagnosis from 807 cancer-related genes. In the discovery phase, tumor tissue and paired adjacent normal mucosa from 92 colorectal patients were analyzed. Bisulphite converted DNA from 92 colorectal tumor samples and paired adjacent normal mucosa were hybridised to the Illumina GoldenGate Methylation Cancer Panel I. Additionally, replicates were hybridised for five tumor tissue and their corresponding normal mucosa for reproducibility purposes, totalling 194 samples. Three samples (SAMPLEs 49, 51, and 162) and 50 loci did not reach the quality criteria required regarding the signal-to-noise ratio and were therefore excluded from further analysis. One additional non-tumoral sample (SAMPLE 15) was removed because it exhibited a methylation pattern quiet different from that shown by the rest of normal specimens, which could be indicative of hybridization errors. These Samples and loci are included in the raw data matrix to allow other investigators to use them if different criteria are applied. They have been also included in the Sample tables with missing values in order to preserve the structure of the data across records/files (See 'data processing' section for more details).

2013-05-27 | E-GEOD-43369 | biostudies-arrayexpress

Homo sapiens

Project description:30 paired normal and tumor colorectal samples

| PRJNA300952 | ENA

DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer

2013-05-27 | GSE43369 | GEO

Plasma Multi-omics Nucleic Acid Landscape of Gastrointestinal Cancer [Tissue RNA-seq]

Project description:We sequenced 30 tissue samples from 15 colorectal cancer patients, including tumor and tumor-adjacent normal tissue (> 2cm from the primary tumor). These patients' plasma has been profiled.

2023-09-28 | GSE211831 | GEO

Project description:16 paired samples of colorectal cancer patients

| PRJNA737203 | ENA

Project description:small RNA profiling in paired tumor and normal breast tissue samples in breast cancer patients

| PRJNA494326 | ENA

DPM1 regulates ER-stress sensor IRE1 activity and antitumor immunity in colorectal cancer

Project description:This study investigates how DPM1 regulates the ER stress sensor IRE1 and how this impacts antitumor immunity in a colorectal cancer model. Single cell data were generated from tumor infiltrating T cells isolated from BALB/c mice bearing CT26 colorectal tumors. Wild-type and Dpm1 knockout tumors were profiled using 10x Genomics Chromium Single Cell 5' gene expression, feature barcode hashtags, and paired TCR VDJ libraries. Raw reads are available in SRA under BioProject PRJNA1435810.

2026-03-16 | GSE324690 | GEO

Proteomic landscape and clinical implications of ovarian carcinosarcoma

Project description:Proteomics of 14 tumor tissue samples and 9 paired normal ovarian tissue samples were collected from 14 ovarian carcinosarcoma patients

2026-03-29 | PXD076330 |

Screening for Epigenetically Masked Genes in Colorectal Cancer using 5-aza-2’-deoxycytidine treatment, Microarray and Gene Expression Profile

Project description:Unearthing of silenced genes in colorectal cancer (CRC) is of great importance. We employed oligonucleotide microarray to find changes in global gene expression of five CRC cell lines. These were analyzed before and after treatment with the 5-aza-2'-Deoxycitidine. Expression of the responding genes was integrated with gene expression profiling generated by microarray analysis of matched colorectal tissue samples. Selected candidates were subjected to methylation-specific PCR (MSP) and real-time quantitative reverse transcription-PCR using CRC cell lines and paired tumor and normal samples from CRC patients. Sixty eight genes were re-expressed after 5-aza-2'-Deoxycitidine treatment and over-expressed in normal colorectal mucosa, including genes that were known to be methylated in CRC. After applying study selection criteria, we identified 16 potential genes. Two candidates were selected (ASPP1 and SCARA5). Among 15 CRC cell lines, methylation was identified in SCARA5 (20%). The methylation status of SCARA5 was subsequently investigated in 23 paired colorectal tissue samples; methylation was detected in 17%, respectively. Observed promoter methylation showed a tendency towards methylation in tumor-derived samples, in SCARA5 gene. Significant down expression of SCARA5 mRNA was observed in CRC cell lines and tumor tissues compared to adjacent normal tissues (P < 0.001 and P = 0.001, respectively). The use of genome-wide screening led to the identification of a group of candidate genes. Among them, SCARA5 was methylated and markedly down-regulated in CRC. SCARA5 gene may have a role in CRC tumorigenesis.

2012-03-20 | GSE32323 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data